Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Regeneron Pharmaceuticals (REGN.VI) Q2 2023 Earnings
REGN.VI
4
May
Confirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
8.44
9.49
10.54
11.6
Details
Expected EPS
8.717903699999999
Actual EPS
9.1533453
Surprise EPS
0.44
Surprise Percent
+4.99%
Description
Regeneron Pharmaceuticals (REGN.VI) has reported earnings of 9.1533453 per share for Q2 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login